Data protection Impressum

Medical Devices

Following a CHF 2.4 million seed round, Bern-based medtech start-up Aseptuva has moved from early prototyping to preclinical validation of its Far-UVC technology designed to prevent catheter-related bloodstream infections, and is now raising a CHF 5 million Series A.

Aseptuva moves to preclinical validation and opens a CHF 5 million Series A round

22 September 2026

The Foundation for Innovation and Technology has awarded CHF 100,000 Tech Seed loans to Dexterous Endoscopes, for an endoscope that switches from flexible to rigid during a procedure, and to Precisia Care, for its hospital data analytics platform.

FIT grants Tech Seed loans to Dexterous Endoscopes and Precisia Care

14 September 2026

The tenth Swiss Medtech Industry Study reports a sector generating CHF 26 billion in sales and growing at twice the rate of the Swiss economy, while flagging a marked slowdown in job creation and investment. Western Switzerland accounts for a substantial share of the country's medtech base.

Swiss medtech grows twice as fast as the economy

14 September 2026

Top Stories Western Switzerland

Top Stories from Western Switzerland (August 2026)

31 August 2026

Distalmotion, the Lausanne-based medtech company, has received FDA 510(k) clearance for ventral hernia repair with its DEXTER Robotic Surgery System, completing its portfolio for the four highest-volume outpatient soft tissue procedures in the United States.

Distalmotion’s DEXTER robot cleared by the FDA for ventral hernia repair

20 August 2026

Spineart, the Geneva-based medtech company specializing in spine surgery, has received FDA approval for its BAGUERA C cervical disc for one and two contiguous levels, expanding access in the United States to a motion-preserving solution for cervical disc disease.

Spineart receives FDA approval for its BAGUERA C cervical disc

20 August 2026

A new study conducted at Bern’s University Hospital shows that VisionOne, the virtual reality eye-testing platform developed by Vaud-based PeriVision, delivers clinical performance comparable to the stationary perimeter considered the gold standard, including in advanced glaucoma.

PeriVision’s VR eye test matches the gold standard across glaucoma severity

17 August 2026

Actival, a CSEM spin-off based in Neuchâtel, has been awarded a CHF 1.4 million grant from Innosuisse to accelerate the development and market launch of its patented Active Splints, a new generation of dental aligners that dispense antibacterial fluid and fluoride.

Actival secures a CHF 1.4 million Innosuisse grant for its smart dental aligners

3 August 2026

HeroSupport, a Geneva-based medtech company, has announced that NYU Grossman School of Medicine is the first clinical site in the United States to participate in its SHIELD study evaluating the VENUS SHELL breast immobilization device.

HeroSupport opens its first US clinical site for the SHIELD study

3 August 2026

The .NeuroRestore center in Lausanne, led by Jocelyne Bloch and Grégoire Courtine, has been honored with the 2026 Grand Prix scientifique of the NRJ Foundation - Institut de France for its brain-spine interface that restores movement to paralyzed patients.

.NeuroRestore wins part of France’s 2026 NRJ Foundation science grand prix

13 July 2026

1 2 3 4 5 … 15